Full Text View
Tabular View
Study Results
Related Studies
Study of Sitagliptin in Older Type 2 Diabetics
This study has been completed.
Study NCT00305604.   Last updated on March 19, 2009.
Information provided by Merck
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
More general conditions related to this trial
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Comparator: sitagliptin phosphate
Comparator: Placebo
Additional drug interventions recognized in this trial
Sitagliptin
More general drug interventions related to this trial
Dipeptidyl-Peptidase IV Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Sponsors listed in this trial
Merck


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services